News Alerts

22 Oct 2020 | 09:20 PM UTC

France: Authorities introduce night-time curfews in additional departments from October 24 /update 48

France News Alert

French authorities introduce (21:00 - 06:00) night-time curfew in additional departments from October 24; follow government directives

TIMEFRAME expected from 10/22/2020, 12:00 AM until 12/1/2020, 11:59 PM (Europe/Paris). COUNTRY/REGION France

Read all related news alert(s):


French authorities announced on Thursday, October 22, that a night-time curfew has been introduced in 38 departments following a significant increase in coronavirus disease (COVID-19) cases in the country. The curfew comes as France reaches over one million confirmed COVID-19 cases on Thursday. Health authorities reported 41,622 cases and 165 associated deaths in the last 24 hours. The nightly curfew will be in place between 21:00 - 06:00 (local time) as of Saturday, October 24, and will be implemented in Ain, Alpes-Maritimes, Ardeche, Ardennes, Ariege, Aube, Aveyron, Bas-Rhin, Calvados, Corse-du-Sud, Cote-d'Or, Drome, Gard, Hautes-Alpes, Haute-Corse, Haute-Loire, Hautes-Pyrenees, Haute-Savoie, Haute-Vienne, Ille-et-Vilaine, Indre-et-Loire, Jura, Loiret, Lozere, Maine-et-Loire, Marne, Meurthe-et-Moselle, Oise, Pas-de -Calais, the Puy-de-Dôme, the Pyrenees-Atlantiques, the Pyrenees-Orientales; Saone-et-Loire, Savoie, Tarn, Tarn-et-Garonne, Var, Vaucluse, and French Polynesia.

Under the measure, people will only be permitted to leave their homes for essential purposes such as hospital visits and critical work duties during the curfew. A fine may be given to those who violate the curfew. The new curfews are expected to be in place until at least December 1.  

France is now the second country in Western Europe to hit over one million cases. It also has the fifth-highest number of cases in the world behind the US, India, Brazil, and Russia.

As of October 22, there have been 1,041,991 confirmed cases of COVID-19 and 34,237 associated fatalities in France. Further international spread of the virus is to expected.


The first case of COVID-19 was reported on December 31 and the source of the outbreak has been linked to a wet market in Wuhan (Hubei province, China). Since then, human-to-human transmission of the virus has been confirmed.

Cases of the virus have been confirmed in numerous countries and territories worldwide. On March 11, the World Health Organization (WHO) declared the global outbreak a pandemic. Virus-screening and quarantining measures are being implemented at airports worldwide, as well as extensive travel restrictions.

The most common symptoms of COVID-19 are fever, dry cough, and tiredness. Some patients may experience other symptoms such as body pains, nasal congestion, headache, conjunctivitis, sore throat, diarrhea, loss of taste or smell, or a rash on the skin or discoloration of fingers or toes. These symptoms (in most cases mild) appear gradually. Generally, most patients (around 80 percent) recover from the disease without being hospitalized.


Measures adopted by local authorities evolve quickly and are usually effective immediately. Depending on the evolution of the outbreak in other countries, authorities are likely to modify, at very short notice, the list of countries whose travelers are subject to border control measures or entry restrictions upon their arrival to the territory in question. It is advised to postpone nonessential travel due to the risk that travelers may be refused entry or be subject to quarantine upon their arrival or during their stay.

To reduce the risk of COVID-19 transmission, travelers are advised to abide by the following measures:

  • Frequently clean hands by applying an alcohol-based hand rub or washing with soap and water.
  • When coughing and sneezing, cover mouth and nose with a flexed elbow or tissue; if used, throw the tissue away immediately and wash hands.
  • If experiencing a fever, cough, difficulty breathing, or any other symptoms suggestive of respiratory illness, including pneumonia, call emergency services before going to the doctor or hospital to prevent the potential spread of the disease.


Copyright and Disclaimer
GardaWorld is the owner or licensee of all intellectual property rights in the material presented on this website. All such rights are reserved. The use of this website and its material is subject to the Terms of Use and accordingly you must not use any content from this website for commercial or other analogous purposes without our consent, including but not limited to any deep-linking or framing in order to copy, distribute, display or monitor any portion of the website. If you have any questions or are interested in distributing any content from this website, Contact us for more details.

Related news